This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by JOHNSTON, D. Articles by MELNYKOVYCH, G. Search for Related Content PubMed PubMed Citation Articles by JOHNSTON, D. Articles by MELNYKOVYCH, G.

Reduction in Cell-Associated Low Density Lipoprotein in Dexamethasone-Treated HeLa Cells: Suggested Mechanism^*

DEAN JOHNSTON, JEANNIE M. ROBSON and GEORGE MELNYKOVYCH

Medical Research Service, Veterans Administration Medical Center Kansas City, Missouri 64128;
the Department of Microbiology, University of Kansas Medical Center Kansas City, Kansas 66103

Address all correspondence and requests for reprints to: George Melnykovych, Ph.D., Medical Research Service (151), Veterans Administration Medical Center, 4801 Linwood Boulevard, Kansas City,Missouri 64128.

Abstract

An earlier study of cholesterol metabolism in HeLa cells has provided evidence for the inhibitory effect of glucocorticoids on de novo cholesterol synthesis. To extend this observation to other regulatory pathways involving cholesterol, we have now determined the effects of dexamethasone on the cell-associated low density lipoprotein (LDL) assumed to represent a normal source of exogenous cholesterol. It was found that HeLa cells internalized LDL by low affinity as well as high affinity saturable processes. Since cell-associated LDL was reduced by dexamethasone to 20–60% of the control value, we have made further attempts to examine the nature of this observation. The kinetics of LDL-cell association and the binding studies performed at 4 C indicated that dexamethasone did not affect the immediate binding of LDL to HeLa cells, whereas 25-hydroxycholesterol, which is known in other cells to inhibit LDL binding by reducing the number of LDL receptors, had the same effect in HeLa cells. The nature of the dexamethasone effect appeared to be related to interference with processing of bound LDL after its internalization. Further evidence that dexamethasone did not affect the initial binding of LDL was provided by the experiments in which chloroquine completely abolished the inhibitory action of dexamethasone. (Endocrinology 113:907,1983)

Footnotes

^* This work was supported in part by the V. A. and NIH Grant CA-08315.

Present address: Department of Dermatology, New York University Medical Center, New York, New York 10016.

Received August 2, 1982.

This article has been cited by other articles:

				B. Igau, G. Castro, V. Clavey, C. Slomianny, R. Bresson, P. Drouin, J.-C. Fruchart, and C. Fievet In Vivo Glucosylated LpA-I Subfraction : Evidence for Structural and Functional Alterations Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 2830 - 2836. [Abstract] [Full Text]